These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12825859)

  • 21. Overexpression of the protein tyrosine phosphatase PRL-2 correlates with breast tumor formation and progression.
    Hardy S; Wong NN; Muller WJ; Park M; Tremblay ML
    Cancer Res; 2010 Nov; 70(21):8959-67. PubMed ID: 20841483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells.
    Nouhi Z; Chughtai N; Hartley S; Cocolakis E; Lebrun JJ; Ali S
    Cancer Res; 2006 Feb; 66(3):1824-32. PubMed ID: 16452244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactin is a local growth factor in rat mammary tumors.
    Mershon J; Sall W; Mitchner N; Ben-Jonathan N
    Endocrinology; 1995 Aug; 136(8):3619-23. PubMed ID: 7628401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolactin as an autocrine/paracrine growth factor in human cancer.
    Ben-Jonathan N; Liby K; McFarland M; Zinger M
    Trends Endocrinol Metab; 2002 Aug; 13(6):245-50. PubMed ID: 12128285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of prolactin receptors (PRL-R) by lactogenic and steroid hormones in human breast cancer cells in long-term tissue culture (T-47D).
    Leroy-Martin B; Peyrat JP
    Anticancer Res; 1989; 9(3):631-6. PubMed ID: 2764510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolactin drives estrogen receptor-alpha-dependent ductal expansion and synergizes with transforming growth factor-alpha to induce mammary tumors in males.
    Arendt LM; Schuler LA
    Am J Pathol; 2008 Jan; 172(1):194-202. PubMed ID: 18156207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation.
    Llovera M; Pichard C; Bernichtein S; Jeay S; Touraine P; Kelly PA; Goffin V
    Oncogene; 2000 Sep; 19(41):4695-705. PubMed ID: 11032019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of prolactin and growth hormone in breast cancer.
    Wennbo H; Törnell J
    Oncogene; 2000 Feb; 19(8):1072-6. PubMed ID: 10713692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer.
    Ormandy CJ; Hall RE; Manning DL; Robertson JF; Blamey RW; Kelly PA; Nicholson RI; Sutherland RL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3692-9. PubMed ID: 9360527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.
    Zhang HT; Craft P; Scott PA; Ziche M; Weich HA; Harris AL; Bicknell R
    J Natl Cancer Inst; 1995 Feb; 87(3):213-9. PubMed ID: 7535859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin synthesis and secretion by human breast cancer cells.
    Ginsburg E; Vonderhaar BK
    Cancer Res; 1995 Jun; 55(12):2591-5. PubMed ID: 7780973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.
    Wennbo H; Gebre-Medhin M; Gritli-Linde A; Ohlsson C; Isaksson OG; Törnell J
    J Clin Invest; 1997 Dec; 100(11):2744-51. PubMed ID: 9389738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin is an autocrine or paracrine growth factor for human myometrial and leiomyoma cells.
    Nowak RA; Mora S; Diehl T; Rhoades AR; Stewart EA
    Gynecol Obstet Invest; 1999; 48(2):127-32. PubMed ID: 10461005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of prolactin and its receptor in human breast carcinoma.
    Reynolds C; Montone KT; Powell CM; Tomaszewski JE; Clevenger CV
    Endocrinology; 1997 Dec; 138(12):5555-60. PubMed ID: 9389544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II.
    Kahán Z; Sun B; Schally AV; Arencibia JM; Cai RZ; Groot K; Halmos G
    Cancer; 2000 Mar; 88(6):1384-92. PubMed ID: 10717621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteolysis of human prolactin: resistance to cathepsin D and formation of a nonangiostatic, C-terminal 16K fragment by thrombin.
    Khurana S; Liby K; Buckley AR; Ben-Jonathan N
    Endocrinology; 1999 Sep; 140(9):4127-32. PubMed ID: 10465285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells.
    Zhang L; Kharbanda S; Hanfelt J; Kern FG
    Cancer Res; 1998 Jan; 58(2):352-61. PubMed ID: 9443417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parathyroid hormone-related protein and bone metastases.
    Guise TA
    Cancer; 1997 Oct; 80(8 Suppl):1572-80. PubMed ID: 9362424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Pit-1/Pou1f1 transcription factor regulates and correlates with prolactin expression in human breast cell lines and tumors.
    Ben-Batalla I; Seoane S; Macia M; Garcia-Caballero T; Gonzalez LO; Vizoso F; Perez-Fernandez R
    Endocr Relat Cancer; 2010 Mar; 17(1):73-85. PubMed ID: 19808898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin Receptor Expression is an Independent Favorable Prognostic Marker in Human Breast Cancer.
    Hachim IY; Hachim MY; Lopez VM; Lebrun JJ; Ali S
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):238-45. PubMed ID: 26317306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.